Transkaryotic Therapies Inc. of Cambridge, Mass., which isdeveloping gene therapies, on Tuesday said it had named K.Michael Forrest as president and chief executive officer. Forrestcomes from Lederle International, a pharmaceutical companywhere he held a variety of executive positions.

(c) 1997 American Health Consultants. All rights reserved.